The withdrawal of torcetrapib from drug development: implications for the future of drugs that alter HDL metabolism
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543784.16.10.1509
Reference26 articles.
1. Efficacy and Safety of Torcetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor, in Individuals With Below-Average High-Density LipoproteinCholesterolLevelsonaBackgroundofAtorvastatin
2. Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease
3. Predictors of Restenosis after Coronary Angioplasty. A Study on Demographic and Metabolic Variables
4. Relation of Gemfibrozil Treatment and Lipid Levels With Major Coronary Events
5. Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Omics Data Integration and Analysis for Systems Pharmacology;Methods in Molecular Biology;2019
2. Carbon–carbon bond cleavage and formation reactions in drug metabolism and the role of metabolic enzymes;Drug Metabolism Reviews;2015-09-22
3. Haemodynamic Assessment in Safety Pharmacology;Principles of Safety Pharmacology;2015
4. Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data;Toxicology;2014-07
5. Pharmacometabonomics and personalized medicine;Annals of Clinical Biochemistry: International Journal of Laboratory Medicine;2013-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3